Bayer’s AskBio Acquisition Strong Statement For Gene Therapy in Europe
This week, German big pharma Bayer announced a €3.5B takeover of Asklepios BioPharmaceutical, a well…
30/10/2020 - 6 minutes
Gene therapy
Sponsored
by Merck
Ensuring Viral Vector Supply for Gene Therapies
While the success of gene therapies has boosted investments in the sector, it has also…
26/10/2020 - 2 minutes
Sponsored
by Biovian
What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?
While the global gene therapy market grows steadily, companies continue to face bottlenecks in the…
28/09/2020 - 7 minutes
Why Are There Only 11 Cell and Gene Therapies in Europe?
There is a lot of talk about how cell and gene therapy are going to…
21/09/2020 - 5 minutes
Why a US Presence Can Help European Biotechs Get Ahead
While there is no doubt that Europe has a thriving biotech scene, it can really…
24/08/2020 - 5 minutes
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
14/08/2020 - 5 minutes
€112M Fund Launched to Commercialize UCL’s Gene Therapy Research
The leading UK institution University College London and the firm AlbionVC have made the first…
06/08/2020 - 2 minutes
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors…
29/07/2020 - 4 minutes
Sponsored
by CEVEC
How to Solve the Production Challenges of AAVs for Gene Therapy
In its rather short life, the gene therapy field has been on a rollercoaster of…
03/06/2020 - 10 minutes
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
19/05/2020 - 5 minutes
Sponsored
by Merck
The Roller Coaster of Gene Therapy Manufacturing
By 2027, the global gene therapy market is estimated to reach a staggering value of…
13/05/2020 - 9 minutes
BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies
US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare,…
07/05/2020 - 2 minutes
